Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Antibody induction therapy for lung transplant recipients

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Telerehabilitation for chronic respiratory disease

    Publikation: Bidrag til tidsskriftReviewpeer review

  2. Antibiotic regimens for early‐onset neonatal sepsis (Protocol)

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Antibiotic regimens for late‐onset neonatal sepsis (Protocol)

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Antibiotics for hospital‐acquired pneumonia in neonates and children (Protocol)

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Interventions for frostbite injuries

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer
Lung transplantation has become a valuable and well-accepted treatment option for most end-stage lung diseases. Lung transplant recipients are at risk of transplanted organ rejection, and life-long immunosuppression is necessary. Clear evidence is essential to identify an optimal, safe and effective immunosuppressive treatment strategy for lung transplant recipients. Consensus has not yet been achieved concerning use of immunosuppressive antibodies against T-cells for induction following lung transplantation.
OriginalsprogEngelsk
TidsskriftCochrane Database of Systematic Reviews
Vol/bind11
Sider (fra-til)CD008927
ISSN1469-493X
DOI
StatusUdgivet - 2013

ID: 41722662